Neuroimaging and Psychiatry: The Long Road from Bench to Bedside

Hastings Center Report

Volumn 44, Issue SUPPL2, 2014, Pages

  Mayberg, Helen S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN; ETHICS; FORECASTING; FUNCTIONAL NEUROIMAGING; HUMAN; MENTAL DISEASE; METHODOLOGY; NEUROIMAGING; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHIATRY;

BRAIN; FORECASTING; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; NEUROIMAGING; NEUROPSYCHIATRY; PREDICTIVE VALUE OF TESTS; PSYCHIATRY;

EID: 84897891532     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1002/hast.296     Document Type: Article

References (53)

1. M. First et al., "Neuroimaging Markers of Psychiatric Disorders: Consensus Report of the APA Work Group," in Resource Documents, American Psychiatric Association, 2012, accessed January 21, 2014, http://www.psychiatry.org/learn/library--archives/resource-documents
2. G. M. Macqueen, "Will There Be a Role for Neuroimaging in Clinical Psychiatry?" Journal of Psychiatry & Neuroscience 35, no. 5 (2010): 291-93.
3. J. L. Shaffer et al., "Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers, " Radiology 266, no. 2 (2013): 583-91.
4. A. J. Stoessl, "Neuroimaging in Parkinson's Disease: From Pathology to Diagnosis, " supplement, Parkinsonism & Related Disorders 18, no. 1 (2012): S55-59.
5. First et al., "Neuroimaging Markers of Psychiatric Disorders: Consensus Report of the APA Work Group."
6. H. C. Whalley et al., "Review of Functional Magnetic Resonance Imaging Studies Comparing Bipolar Disorder and Schizophrenia," Bipolar Disorders 14, no. 4 (2012): 411-31
7. D. Linden and J. Thome, "Modern Neuroimaging in Psychiatry: Towards the Integration of Functional and Molecular Information," supplement, World Journal of Biological Psychiatry 12, no. 1 (2011): 6-10
8. G. Pastura et al., "Advanced Techniques in Magnetic Resonance Imaging of the Brain in Children with ADHD," Arquivos de Neuropsiquiatria 69, no. 2A (2011): 242-52
9. A. M. Cusi et al., "Systematic Review of the Neural Basis of Social Cognition in Patients with Mood Disorders," Journal of Psychiatry & Neuroscience 37, no. 3 (2012): 154-69
10. K. Holzschneider and C. Mulert, "Neuroimaging in Anxiety Disorders," Dialogues in Clinical Neuroscience 13, no. 4 (2011): 453-61
11. M. A. Parvaz et al., "Neuroimaging for Drug Addiction and Related Behaviors," Reviews in the Neurosciences 22, no. 6 (2011): 609-24
12. E. A. Hazlett, K. E. Goldstein, and J. C. Kolaitis, "A Review of Structural MRI and Diffusion Tensor Imaging in Schizotypal Personality Disorder," Current Psychiatry Reports 14, no. 1 (2012): 70-78.
13. H. S. Mayberg, "Frontal Lobe Dysfunction in Secondary Depression," Journal of Neuropsychiatry and Clinical Neurosciences 6 (1994): 428-42
14. H. S. Mayberg, "Limbic-Cortical Dysregulation: A Proposed Model of Depression," Journal of Neuropsychiatry & Clinical Neurosciences 9 (1997): 471-81
15. H. S. Mayberg, "Targeted Electrode-Based Modulation of Neural Circuits for Depression," Journal of Clinical Investigation 119, no. 4 (2009): 717-25.
16. C. Fu, H. Steiner, and S. Costafreda, "Predictive Neural Biomarkers of Clinical Response in Depression: A Meta-analysis of Functional and Structural Neuroimaging Studies of Pharmacological and Psychological Therapies, Neurobiology of Disease 52 (2012): 75-83
17. J. B. Savitz and W. C. Drevets, "Neuroreceptor Imaging in Depression," Neurobiology of Disease 52 (2012): 49-46.
18. J. L. Price and W. C. Drevets, "Neural Circuits Underlying the Pathophysiology of Mood Disorders, " Trends in Cognitive Sciences 16, no. 1 (2012): 61-71.
19. First et al., "Neuroimaging Markers of Psychiatric Disorders: Consensus Report of the APA Work Group." For further discussion of the general difficulties associated with using fMRI to diagnose psychiatric disorders
20. S. Gillihan and E. Parens, "Should We Expect 'Neural Signatures' for DSM Diagnoses?," Journal of Clinical Psychiatry 72, no. 10 (2011): 1383-89.
21. H. S. Mayberg et al., "Regional Metabolic Effects of Fluoxetine in Major Depression: Serial Changes and Relationship to Clinical Response," Biological Psychiatry 48, no. 8 (2000): 830-43
22. A. L. Brody et al., "Regional Brain Metabolic Changes in Patients with Major Depression Treated with Either Paroxetine or Interpersonal Therapy: Preliminary Findings," Archives of General Psychiatry 58, no. 7 (2001): 631-40
23. K. Goldapple et al., "Modulation of Cortical- Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy," Archives of General Psychiatry 61, no. 1 (2004): 34-41
24. S. H. Kennedy et al., "Differences in Brain Glucose Metabolism between Responders to CBT and Venlafaxine in a 16- Week Randomized Controlled Trial," American Journal of Psychiatry 164, no. 5 (2007): 778-88
25. C. R. Conway et al., "Cerebral Blood Flow Changes during Vagus Nerve Stimulation for Depression," Psychiatric Research 146, no. 2 (2006): 179-84
26. H. S. Mayberg et al., "Deep Brain Stimulation for Treatment-Resistant Depression," Neuron 45, no. 5 (2005): 651-60
27. J. Z. Konarski et al., "Predictors of Non-response to Cognitive Behavioural Therapy or Venlafaxine Using Glucose Metabolism in Major Depressive Disorder," Journal of Psychiatry and Neuroscience 34 (2009): 175-80.
28. Mayberg, "Targeted Electrode-Based Modulation of Neural Circuits for Depression" Mayberg, "Modulating Dysfunctional Limbic-Cortical Circuits in Depression: Towards Development of Brain-Based Algorithms for Diagnosis and Optimised Treatment."
29. B. N. Gaynes et al., "What Did STAR*D Teach Us? Results from a Large-Scale, Practical, Clinical Trial for Patients with Depression," Psychiatric Services 60, no. 11 (2009): 1439-45
30. B. N. Gaynes et al., "Treating Depression after Initial Treatment Failure: Directly Comparing Switch and Augmenting Strategies in STAR*D," Journal of Clinical Psychopharmacology 32, no. 1 (2012): 114-19
31. B. W. Dunlop et al., "Depression Beliefs, Treatment Preference, and Outcomes in a Randomized Trial for Major Depressive Disorder," Journal of Psychiatric Research 46, no. 3 (2012): 375-81.
32. F. M. Quitkin et al., "Columbia Atypical Depression: A Subgroup of Depressives with Better Response to MAOI Than to Tricyclic Antidepressants or Placebo," supplement, The British Journal of Psychiatry, no. 21 (1993): 30-34
33. N. Müller, A. M. Myint, and M. J. Schwarz, "Inflammatory Biomarkers and Depression," Neurotoxicity Research 19, no. 2 (2011): 308-18
34. G. W. Arana, R. J. Baldessarini, and M. Ornsteen, "The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review," Archives of General Psychiatry 42, no. 12 (1985): 1193-204
35. M. Ising et al., "A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression," Archives of General Psychiatry 66, no. 9 (2009): 966-75.
36. T. D. Welch et al., "Modern Management of Acute Myocardial Infarction, " Current Problems in Cardiology 37, no. 7 (2012): 237-310.
37. T. D. Saijo, "Critical Comments for Roles of Biomarkers in the Diagnosis and Treatment of Cancer, " Cancer Treatment Reviews 38, no. 1 (2012): 6-67.
38. H. S. Mayberg et al., "Cingulate Function in Depression: a Potential Predictor of Treatment Response," Neuroreport 8, no. 4 (1997): 1057-61
39. J. Wu et al., "Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex," The American Journal of Psychiatry 156, no. 8 (1999): 1149-58
40. T. A. Ketter et al., "Baseline Cerebral Hypermetabolism Associated with Carbamazepine Response, and Hypometabolism with Nimodipine Response in Mood Disorders," Biological Psychiatry 46, no. 10 (1999): 1364- 74 D. Pizzagalli et al., "Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis," The American Journal of Psychiatry 158, no. 3 (2001): 405-15
41. D. Pizzagalli et al., "Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis," The American Journal of Psychiatry 158, no. 3 (2001): 405-15
42. D. D. Dougherty et al., "Cerebral Metabolic Correlates as Potential Predictors of Response to Anterior Cingulotomy for Treatment of Major Depression," Journal of Neurosurgery 99, no. 6 (2003): 1010-17
43. J. Z. Konarski et al., "Predictors of Nonresponse to Cognitive Behavioural Therapy or Venlafaxine Using Glucose Metabolism in Major Depressive Disorder," Journal of Psychiatry & Neuroscience 34, no. 3 (2009): 175-80
44. A. F. Leuchter et al., "Comparative Effectiveness of Biomarkers and Clinical Indicators for Predicting Outcomes of SSRI Treatment in Major Depressive Disorder: Results of the BRITE-MD Study," Psychiatry Research 169, no. 2 (2009): 124-31
45. C. DeBattista et al., "The Use of Referenced-EEG (rEEG) in Assisting Medication Selection for the Treatment of Depression," Journal of Psychiatric Research 45, no. 1 (2011): 64-75
46. Savitz and Drevets, "Neuroreceptor Imaging in Depression."
47. Mayberg, "Modulating Dysfunctional Limbic-Cortical Circuits in Depression: Towards Development of Brain-Based Algorithms for Diagnosis and Optimised Treatment"
48. S. Kapur, A. G. Phillips, and T. R. Insel, "Why Has It Taken So Long for Biological Psychiatry to Develop Clinical Tests and What to Do about It?" Molecular Psychiatry 17, no. 12 (2012): 1174-79
49. S. H. Kennedy et al., "The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction," Current Pharmaceutical Design 18, no. 36 (2012): 5976-89
50. See C. L. McGrath et al., "Toward Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder," JAMA Psychiatry 70, no. 8 (2013): 821-29, doi: 0.1001/jamapsychiatry.2013.143
51. C. L. McGrath et al., "Pre-treatment Brain States Identify Likely Failures to Standard Treatments for Depression," Biological Psychiatry, epub, http://dx.doi.org/10.1016/j.biopsych.2013.12.005.
52. First et al., "Neuroimaging Markers of Psychiatric Disorders: Consensus Report of the APA Work Group"
53. M. J. Farah and S. J. Gillihan, "The Puzzle of Neuroimaging and Psychiatric Diagnosis: Technology and Nosology in an Evolving Discipline," American Journal of Bioethics Neuroscience 3 (2012): 31-41